AstraZeneca
covid vaccine shown to be safe and effective in clinical trials and real world data | AstraZeneca
Company
Deck Type
Sector
Industry
Deck date
March 2021
Slide
27 of 86
Related slides by other companies
GreenLight
SPAC
August 2021
promising influenza vaccine candidate high levels of antibody production and protection against viral challenge | GreenLight
Crowdstrike
Investor Presentation
March 2023
at a glance leader in cloud delivered protection of cloud identity and data | Crowdstrike
BioNTech
Results
November 2021
clinical strategy supports boosters and platform approach to variants clinical trials evaluating booster dose for immunogenicity and vaccine efficacy trials evaluating variant encoding vaccines support flexible platform approach to product adaptation | BioNTech
Revelation Biosciences
Investor Presentation
October 2022
program highlights scientific rationale or transmission still active poor mucosal protection on robust mucosal protection vaccine adjuvant market growth nonclinical study in progress data | Revelation Biosciences
Other recent decks by AstraZeneca
See all presentations (31 decks)
Results
February 2025
Results
November 2024
Results
November 2024
Investor Event
September 2024
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights